343 related articles for article (PubMed ID: 31715006)
1. Percutaneous left atrial appendage closure, a safe alternative to anticoagulation for patients with nonvalvular atrial fibrillation and end-stage renal disease on hemodialysis: A single center experience.
Xipell M; Flores-Umanzor E; Ojeda R; Arias M; Cepas-Guillén PL; Regueiro A; Freixa X; Cases A; Maduell F
Artif Organs; 2020 May; 44(5):513-521. PubMed ID: 31715006
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous Left Atrial Appendage Closure in Patients with Non-Valvular Atrial Fibrillation and End-Stage Renal Disease on Hemodialysis: A Case Series.
Basabe E; De La Flor JC; López de la Manzanara V; Nombela-Franco L; Narváez-Mejía C; Cruzado L; Villa D; Zamora R; Tapia M; Sastre MÁ; López Soberón E; Herrero Calvo JA; Suárez A; Martí Sánchez D
Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399519
[TBL] [Abstract][Full Text] [Related]
3. [Safety and effectiveness of left atrial appendage occlusion in patients with atrial fibrillation and end-stage renal disease undergoing long-term hemodialysis].
Dai WL; Yao KX; Jiang C; Yang R; Li SN; Long DY; Jia CQ; Li X; Wu JH; Du X; Dong JZ; Ma CS
Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Sep; 49(9):880-885. PubMed ID: 34530595
[No Abstract] [Full Text] [Related]
4. Left atrial appendage occlusion in recurrent ischaemic stroke, a multicentre experience.
Galloo X; Carmeliet T; Prihadi EA; Lochy S; Scott B; Verheye S; Schoors D; Vermeersch P
Acta Clin Belg; 2022 Apr; 77(2):255-260. PubMed ID: 32951514
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous left atrial appendage occlusion procedures in patients with heart failure.
Szymała M; Streb W; Mitręga K; Podolecki T; Mencel G; Kukulski T; Kalarus Z
Kardiol Pol; 2017; 75(9):868-876. PubMed ID: 28612910
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Chinese Patients with Nonvalvular Atrial Fibrillation: A Single-center, Prospective, Observational Study.
Huang WP; Zhang YH; He L; Su X; Yang XW; Guo ZX
Chin Med J (Engl); 2017 Feb; 130(4):434-438. PubMed ID: 28218217
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter left atrial appendage occlusion in patients with chronic kidney disease: a systematic review and meta-analysis.
Flores-Umanzor E; Asghar A; Cepas-Guillén PL; Farrell A; Keshvara R; Alvarez-Rodriguez L; Osten M; Freixa X; Horlick E; Abrahamyan L
Clin Res Cardiol; 2023 Dec; ():. PubMed ID: 38112741
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of the presence of chronic kidney disease on percutaneous left trial appendage closure for atrial fibrillation: A single center experience.
Benini Tapias J; Flores-Umanzor E; Cepas-Guillén PL; Regueiro A; Sanchís L; Broseta JJ; Cases A; Freixa X
Nefrologia (Engl Ed); 2022; 42(3):290-300. PubMed ID: 36210618
[TBL] [Abstract][Full Text] [Related]
9. [Atrial fibrillation in severe and end stage renal disease: from oral anticoagulation therapy to percutaneous left atrial appendage occlusion].
Merella P; Casu G; Mazzone P; Lorenzoni G; D'Angelo G; Genovesi S
G Ital Nefrol; 2019 Feb; 36(1):. PubMed ID: 30758149
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of left atrial appendage occlusion in patients with atrial fibrillation and end stage renal disease.
Chang SN; Tsai CF; Lin TT; Chiu FC; Hsu JC; Chua SK; Cheng HL; Ho LT; Huang PS; Chen JJ; Wu CK; Wang YC; Hwang JJ; Tsai CT
J Formos Med Assoc; 2024 Jan; 123(1):116-122. PubMed ID: 37394333
[TBL] [Abstract][Full Text] [Related]
11. Dual antiplatelet therapy after percutaneous left atrial appendage occlusion: single center experience with the Amplatzer Cardiac Plug.
Bertrand PB; Habran M; Kenis K; Lecomte J; Moonen L; Stroobants D; Benit E
Acta Cardiol; 2019 Feb; 74(1):74-81. PubMed ID: 29607737
[TBL] [Abstract][Full Text] [Related]
12. Indications for percutaneous left atrial appendage occlusion in hospitalized patients with atrial fibrillation.
Vrana E; Kartas A; Samaras A; Vasdeki D; Forozidou E; Liampas E; Karvounis H; Giannakoulas G; Tzikas A
J Cardiovasc Med (Hagerstown); 2022 Mar; 23(3):176-182. PubMed ID: 34580251
[TBL] [Abstract][Full Text] [Related]
13. Left atrial appendage occlusion in patients with atrial fibrillation and large prevalence of prior intracranial bleeding.
Barocelli F; Coli S; Crocamo A; Guidorossi A; Cattabiani MA; Preti F; Bosi D; Spaziani C; Lina D; Menozzi A; Solinas E; Pelà G; Vignali L
J Cardiovasc Med (Hagerstown); 2020 Aug; 21(8):583-591. PubMed ID: 32443136
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous left atrial appendage closure versus non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation and high bleeding risk.
Godino C; Melillo F; Bellini B; Mazzucca M; Pivato CA; Rubino F; Figini F; Mazzone P; Della Bella P; Margonato A; Colombo A; Montorfano M
EuroIntervention; 2020 Apr; 15(17):1548-1554. PubMed ID: 31845892
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study.
Korsholm K; Valentin JB; Damgaard D; Diener HC; Camm AJ; Landmesser U; Hildick-Smith D; Johnsen SP; Nielsen-Kudsk JE
Int J Cardiol; 2022 Sep; 363():56-63. PubMed ID: 35780932
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous Left Atrial Appendage Occlusion: An Emerging Option in Patients with Atrial Fibrillation at High Risk of Bleeding.
Cimmino G; Loffredo FS; Gallinoro E; Prozzo D; Fabiani D; Cante L; Salerno G; Cappelli Bigazzi M; Golino P
Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34063719
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes and periprocedural safety and efficacy of percutaneous left atrial appendage closure in a United Kingdom tertiary center: An 11-year experience.
Briosa E Gala A; Pope MTB; Monteiro C; Leo M; Dawkins S; Newton JD; Betts TR
Heart Rhythm; 2021 Oct; 18(10):1724-1732. PubMed ID: 34126270
[TBL] [Abstract][Full Text] [Related]
18. Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience.
Chun KR; Bordignon S; Urban V; Perrotta L; Dugo D; Fürnkranz A; Nowak B; Schmidt B
Heart Rhythm; 2013 Dec; 10(12):1792-9. PubMed ID: 23973952
[TBL] [Abstract][Full Text] [Related]
19. Impact of chronic kidney disease on Watchman implantation: experience with 300 consecutive left atrial appendage closures at a single center.
Xue X; Jiang L; Duenninger E; Muenzel M; Guan S; Fazakas A; Cheng F; Illnitzky J; Keil T; Yu J
Heart Vessels; 2018 Sep; 33(9):1068-1075. PubMed ID: 29564543
[TBL] [Abstract][Full Text] [Related]
20. Left Atrial Appendage Occlusion Versus Oral Anticoagulation in Atrial Fibrillation : A Decision Analysis.
Chew DS; Zhou K; Pokorney SD; Matchar DB; Vemulapalli S; Allen LA; Jackson KP; Samad Z; Patel MR; Freeman JV; Piccini JP
Ann Intern Med; 2022 Sep; 175(9):1230-1239. PubMed ID: 35969865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
